We are creating centers of excellence in dermatology, oncology and respiratory therapy. The effort is to develop advance therapies to enrich the lives of patients worldwide.

Our Therapeutic Strength

We dedicate ourselves to address the unmet medical needs of patients through innovation. We believe that the best way to help patients meet their evolving needs is by focusing on offering novel products for targeted therapies. Dermatology, Oncology and Respiratory are the focus areas for Glenmark.

Our journey began over 40 years ago with our first product ‘Candid’, which has stood the test of time to remain a market leader even today across multiple geographies. Glenmark is committed to ensuring that patients get the best treatment available by developing breakthrough medicines in this therapy segment.

Glenmark is prepared to emerge as a proficient end-to-end provider of respiratory products and devices worldwide, courtesy of our capable team, strong research infrastructure and cutting-edge manufacturing resources.

We have more than 480 scientists in our R&D centres dedicated to finding new ways to enrich the lives of patients and their families across the world.